Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus

Alberta Hoi; Fabien Bernard Vincent; Margaret L. Hibbs

doi:10.1007/978-3-030-85161-3_1

Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus

Alberta Hoi, Fabien Bernard Vincent, Margaret L. Hibbs

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

Abstract

The scope of this textbook is to provide an overview of the latest translational research in the field of lupus pathogenesis, with particular emphasis on how these discoveries progress in parallel with therapeutic drug development. Systemic lupus erythematosus (SLE) is a multifaceted disease with a number of well-defined immune pathways that are dysregulated, resulting in an immune-mediated chronic inflammatory injury at target organs. As knowledge of these pathways evolves to provide opportunities for targeted drug therapy and lays the foundation for personalized medicine, clinicians and researchers need to keep up with the ever-expanding medical and scientific literature.

Original language	English
Title of host publication	Pathogenesis of Systemic Lupus Erythematosus
Subtitle of host publication	Insights from Translational Research
Editors	Alberta Hoi
Place of Publication	Cham Switzerland
Publisher	Springer
Chapter	1
Pages	1-8
Number of pages	8
Edition	1st
ISBN (Electronic)	9783030851613
ISBN (Print)	9783030851606
DOIs	https://doi.org/10.1007/978-3-030-85161-3_1
Publication status	Published - 2021

Access to Document

10.1007/978-3-030-85161-3_1

Cite this

@inbook{098d3cf04d0340e8b0fe89a8c1518a63,

title = "Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus",

abstract = "The scope of this textbook is to provide an overview of the latest translational research in the field of lupus pathogenesis, with particular emphasis on how these discoveries progress in parallel with therapeutic drug development. Systemic lupus erythematosus (SLE) is a multifaceted disease with a number of well-defined immune pathways that are dysregulated, resulting in an immune-mediated chronic inflammatory injury at target organs. As knowledge of these pathways evolves to provide opportunities for targeted drug therapy and lays the foundation for personalized medicine, clinicians and researchers need to keep up with the ever-expanding medical and scientific literature.",

author = "Alberta Hoi and Vincent, {Fabien Bernard} and Hibbs, {Margaret L.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2021",

doi = "10.1007/978-3-030-85161-3_1",

language = "English",

isbn = "9783030851606",

pages = "1--8",

editor = "Alberta Hoi",

booktitle = "Pathogenesis of Systemic Lupus Erythematosus",

publisher = "Springer",

edition = "1st",

}

Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus. / Hoi, Alberta ; Vincent, Fabien Bernard ; Hibbs, Margaret L.
Pathogenesis of Systemic Lupus Erythematosus: Insights from Translational Research. ed. / Alberta Hoi. 1st. ed. Cham Switzerland: Springer, 2021. p. 1-8.

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

TY - CHAP

T1 - Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus

AU - Hoi, Alberta

AU - Vincent, Fabien Bernard

AU - Hibbs, Margaret L.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2021

Y1 - 2021

N2 - The scope of this textbook is to provide an overview of the latest translational research in the field of lupus pathogenesis, with particular emphasis on how these discoveries progress in parallel with therapeutic drug development. Systemic lupus erythematosus (SLE) is a multifaceted disease with a number of well-defined immune pathways that are dysregulated, resulting in an immune-mediated chronic inflammatory injury at target organs. As knowledge of these pathways evolves to provide opportunities for targeted drug therapy and lays the foundation for personalized medicine, clinicians and researchers need to keep up with the ever-expanding medical and scientific literature.

AB - The scope of this textbook is to provide an overview of the latest translational research in the field of lupus pathogenesis, with particular emphasis on how these discoveries progress in parallel with therapeutic drug development. Systemic lupus erythematosus (SLE) is a multifaceted disease with a number of well-defined immune pathways that are dysregulated, resulting in an immune-mediated chronic inflammatory injury at target organs. As knowledge of these pathways evolves to provide opportunities for targeted drug therapy and lays the foundation for personalized medicine, clinicians and researchers need to keep up with the ever-expanding medical and scientific literature.

UR - http://www.scopus.com/inward/record.url?scp=85153639347&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-85161-3_1

DO - 10.1007/978-3-030-85161-3_1

M3 - Chapter (Book)

AN - SCOPUS:85153639347

SN - 9783030851606

SP - 1

EP - 8

BT - Pathogenesis of Systemic Lupus Erythematosus

A2 - Hoi, Alberta

PB - Springer

CY - Cham Switzerland

ER -

Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus

Abstract

Access to Document

Other files and links

Research output

Pathogenesis of Systemic Lupus Erythematosus: Insights from Translational Research

Cite this